Interleukin 2 exerts autocrine stimulation on murine T-cell leukaemia growth

Br J Cancer. 1997;75(7):946-50. doi: 10.1038/bjc.1997.165.

Abstract

As it has been suggested that an autocrine mechanism may control tumour cell growth, in this work cells from a spontaneous murine T lymphocyte leukaemia (LB) expressing the interleukin-2 receptor (IL-2R) (CD25) were evaluated in vitro for IL-2-mediated autocrine growth. Cells grew readily in culture and proliferation was enhanced by the addition of recombinant IL-2 but inhibited by monoclonal antibodies against either IL-2 or IL-2 receptor, in the absence of exogenous IL-2. Cyclosporin A also inhibited LB cell growth. However, when exogenous IL-2 was added together with cyclosporin A, cell proliferation proved similar to controls. Using reverse transcription polymerase chain reaction (PCR), mRNA for IL-2 was found to be present in tumour cells. Our findings support the hypothesis that LB tumour cell proliferation is mediated by an autocrine pathway involving endogenous IL-2 generation, despite the fact that these cells are not dependent on exogenous IL-2 to grow in culture.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Division / drug effects
  • Cyclosporine / pharmacology
  • Female
  • Gene Expression Regulation, Neoplastic
  • Immunosuppressive Agents / pharmacology
  • Interleukin-2 / physiology*
  • Leukemia, T-Cell / pathology*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Receptors, Interleukin-2 / physiology

Substances

  • Immunosuppressive Agents
  • Interleukin-2
  • Receptors, Interleukin-2
  • Cyclosporine